Stock Report: Star Scientific Inc. (STSI) Report Updated: May 20, 2013 | Print This Page

Star Scientific, Inc., engages in the development, implementation, and licensing of tobacco curing technology that prevents the formation of carcinogenic toxins present in tobacco and tobacco smoke, primarily the tobacco-specific nitrosamines (TSNAs). It is also involved in the development, manufacture, marketing, and sale of very low-TSNA dissolvable smokeless tobacco products, including ARIVA compressed powdered tobacco cigalett pieces, STONEWALL Hard snuff, and modified risk tobacco products. In addition, the company develops, manufactures, markets, and sells nutraceutical dietary supplements, such as Anatabloc for anti-inflammatory support, and CigRx, a tobacco alternative for the maintenance of healthy metabolism. Further, it develops dietary supplements and pharmaceutical products that have a botanical-based component to treat tobacco dependence and a range of neurological conditions, including Alzheimer’s disease, Parkinson’s disease, schizophrenia, and depression. The company sells its products through distributors in the United States. Star Scientific, Inc. was founded in 2000 and is based in Glen Allen, Virginia.